fda approval bpc-157 WHY IT WILL NEVER BE APPROVED | Stefano M. Sinicropi, MD BPC 157 Banned: Key Facts

Immediate patient rescue from benzodiazepine overdose

The primary inflammatory drivers are TNF-alpha, IL-6, and IL-1-beta, all of which are targeted by multiple peptides on this list

New customer

The breadth of documented activity reflects what the original investigators have described as systems-level pharmacology: rather than acting through a single high-affinity receptor, BPC-157 appears to modulate multiple intersecting cellular pathways including nitric oxide signalling, growth-factor receptor expression, dopamine and serotonin metabolism, and angiogenic vessel formation

In fact, if you don't have a B12 deficiency or an underlying health condition that places you at risk of a deficiency, you will see no benefits from high dose B12 shots, says Dr

This pattern reflects BPC-157 working better for fresh tissue damage than established chronic problems